#USA #Palo Alto #TMS #AMPA #Doug Nemecek

Ampa Appoints Dr. Doug Nemecek as Advisor

In a strategic move to bolster its payer strategies and improve outcomes in transcranial magnetic stimulation (TMS) care, Ampa, a neurotechnology innovator based in Palo Alto, has welcomed Dr. Doug Nemecek as an advisor. Dr. Nemecek, who previously served as the Chief Medical Officer for Behavioral Health at The Cigna Group, brings over two decades of experience in leading clinical strategies for behavioral health services, catering to over 16 million members.

Dr. Nemecek played a pivotal role at Cigna, overseeing various aspects such as coverage policies, network designs, and initiatives aimed at aligning clinical outcomes with cost efficiency. His extensive knowledge and expertise will be invaluable for Ampa, particularly regarding their payer strategy and the development of evidence that supports the reimbursement processes for their TMS technology.

CEO of Ampa, Don Vaughn, mentioned, "Doug has spent his career shaping how behavioral health care is evaluated, delivered, and reimbursed. His insights will assist us in broadening reimbursement opportunities while enhancing the standards of quality and outcomes in TMS care."

The incorporation of Dr. Nemecek’s insights comes at a crucial time when there is a growing emphasis on the quality of mental health care delivery and its outcomes. Improving access to effective treatment options such as TMS is a priority for many health plans, and Ampa aims to align these objectives with its innovative technology.

In this advisory role, Dr. Nemecek will help shape Ampa’s strategies regarding reimbursement and payer access. He will also provide guidance on how the company can effectively generate the evidence that health plans require to establish comprehensive coverage pathways for TMS. Dr. Nemecek stated, "The future of behavioral health care relies on delivering consistent, high-quality treatment that demonstrates meaningful outcomes while ensuring alignment across clinicians, patients, and payers. Ampa is combining advanced brain stimulation technology with the necessary data and clinical infrastructure to support a comprehensive, outcomes-oriented care model. I’m excited to support this team as they develop new care models aimed at expanding access and driving improved clinical outcomes."

The Vision of Ampa

Ampa is focused on making TMS more measurable, scalable, and appropriate for mental health treatments. The company’s flagship product, the Ampa One, represents a leap in portable, connected TMS systems and is specifically designed by clinicians for clinicians. By fostering easier treatment delivery and emphasizing quality tracking alongside outcomes-oriented care, Ampa is setting a new standard in the mental health field.

As Ampa progresses with the collaboration from Dr. Nemecek, it is well-positioned to enhance the accessibility and efficacy of TMS therapy, ultimately benefiting a greater number of individuals seeking mental health support. For those interested in learning more about Ampa or scheduling a demonstration of the Ampa One system, additional information is available on their website at www.ampahealth.com.